166 related articles for article (PubMed ID: 11343383)
1. DNA content of granulocytes, monocytes, and lymphocytes in the bone marrow smears of patients with myelodysplastic syndromes.
Widell S; Hast R; Cox C; Auer G; Bennett JM
Am J Hematol; 2001 Jun; 67(2):112-8. PubMed ID: 11343383
[TBL] [Abstract][Full Text] [Related]
2. Methodological aspects of DNA image cytometry in normal bone marrow smears.
Widell S; Czader M; Porwit A; Reizenstein P; Hast R; Auer G
Anal Cell Pathol; 1993 Nov; 5(6):367-76. PubMed ID: 7508257
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of flow cytometric assessment of myeloid nuclear differentiation antigen expression as a diagnostic marker for myelodysplastic syndromes in a series of 269 patients.
Bellos F; Alpermann T; Gouberman E; Haferlach C; Schnittger S; Haferlach T; Kern W
Cytometry B Clin Cytom; 2012 Sep; 82(5):295-304. PubMed ID: 22508616
[TBL] [Abstract][Full Text] [Related]
4. [Cell clonality in myelodysplastic syndrome].
Krejcová H; Neuwirtová R; Cermák J; Belicková M; Brdicka R
Sb Lek; 2002; 103(3):339-48. PubMed ID: 12688178
[TBL] [Abstract][Full Text] [Related]
5. DNA image cytometry in MDS bone marrow smears.
Widell S; Hast R; Auer G; Cox C; Bennett JM
Br J Haematol; 1999 Jun; 105(4):960-5. PubMed ID: 10554807
[TBL] [Abstract][Full Text] [Related]
6. [The implications of the biological indices examination of bone marrow cells in myelodysplastic syndromes].
Zhang F; Hao Y; Pang W
Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):528-32. PubMed ID: 11769678
[TBL] [Abstract][Full Text] [Related]
7. [Study on the burden of abnormal hematopoietic clone of the patients with myelodysplastic syndromes and its implications].
Wang HQ; Shao ZH; Shi J; Cao YR; Liu H; Bai J; Tu MF; Xing LM; Cui ZZ; Liu SH; Sun J; Jia HR; Yang TY
Zhonghua Xue Ye Xue Za Zhi; 2005 Aug; 26(8):473-6. PubMed ID: 16383238
[TBL] [Abstract][Full Text] [Related]
8. Comparison of acute myeloid leukemia occurring de novo or preceded by a myelodysplastic stage: differences in cellular DNA content.
Widell S; Auer G; Hast R; Reizenstein P
Am J Hematol; 1993 Mar; 42(3):293-8. PubMed ID: 8438903
[TBL] [Abstract][Full Text] [Related]
9. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
Wu LY; Li X; Chang CK; Ying SX; Pu Q
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
[TBL] [Abstract][Full Text] [Related]
10. [Preliminary study of biological characteristics of myelodysplastic syndromes clonal cells].
Li X; Wu LY; Ying SX; Chang CK; He Q; Song LQ; Pu Q
Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):478-83. PubMed ID: 18072633
[TBL] [Abstract][Full Text] [Related]
11. Surface marker abnormalities in myelodysplastic syndromes.
Elghetany MT
Haematologica; 1998 Dec; 83(12):1104-15. PubMed ID: 9949628
[TBL] [Abstract][Full Text] [Related]
12. Multiparameter flow cytometric analysis reveals low percentage of bone marrow hematogones in myelodysplastic syndromes.
Maftoun-Banankhah S; Maleki A; Karandikar NJ; Arbini AA; Fuda FS; Wang HY; Chen W
Am J Clin Pathol; 2008 Feb; 129(2):300-8. PubMed ID: 18208811
[TBL] [Abstract][Full Text] [Related]
13. Monosomy 7 in granulocytes and monocytes in myelodysplastic syndrome.
Kere J; Ruutu T; de la Chapelle A
N Engl J Med; 1987 Feb; 316(9):499-503. PubMed ID: 2880296
[TBL] [Abstract][Full Text] [Related]
14. Prognostic importance of hypodiploid hemopoietic precursors in myelodysplastic syndromes.
Clark R; Peters S; Hoy T; Smith S; Whittaker K; Jacobs A
N Engl J Med; 1986 Jun; 314(23):1472-5. PubMed ID: 3702962
[TBL] [Abstract][Full Text] [Related]
15. Maturation-associated immunophenotypic abnormalities in bone marrow B-lymphocytes in myelodysplastic syndromes.
Ribeiro E; Matarraz Sudón S; de Santiago M; Lima CS; Metze K; Giralt M; Saad ST; de Matos AO; Lorand-Metze I
Leuk Res; 2006 Jan; 30(1):9-16. PubMed ID: 16005514
[TBL] [Abstract][Full Text] [Related]
16. Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes.
Tauro S; Hepburn MD; Bowen DT; Pippard MJ
Haematologica; 2001 Oct; 86(10):1038-45. PubMed ID: 11602409
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J
Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
[TBL] [Abstract][Full Text] [Related]
18. Primitive hematopoietic stem cells shows a polyclonal pattern in myelodysplastic syndromes.
Guidetti F; Grazioli S; Capelli F; Marini C; Gallicchio M; De Micheli D; Castello L; Sainaghi PP; Fra GP; Saglio G; Avanzi GC
Haematologica; 2004 Jan; 89(1):21-8. PubMed ID: 14754602
[TBL] [Abstract][Full Text] [Related]
19. [Study on apoptosis in myelodysplastic syndromes by DNA in situ end labelling combined with APAAP].
Li X; Pu Q; Liu Y; Shi J; Tao Y; Chang C; Jiang Q; Huang W
Zhonghua Xue Ye Xue Za Zhi; 2002 Jan; 23(1):27-9. PubMed ID: 12015085
[TBL] [Abstract][Full Text] [Related]
20. Fas/Fas-ligand expressions in peripheral-blood mononuclear cells of patients with myelodysplastic syndromes.
Hirano T; Hiratsuka N; Iwahori T; Oka K; Wakasugi K
Res Commun Mol Pathol Pharmacol; 2003; 113-114():315-28. PubMed ID: 15686130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
